These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8618110

  • 1. Betalactam therapy and intestinal flora.
    Novelli A, Mazzei T, Fallani S, Dei R, Cassetta MI, Conti S.
    J Chemother; 1995 May; 7 Suppl 1():25-31. PubMed ID: 8618110
    [Abstract] [Full Text] [Related]

  • 2. The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
    Rodriguez WJ, Wiedermann BL.
    Adv Pediatr Infect Dis; 1994 May; 9():125-59. PubMed ID: 8123221
    [No Abstract] [Full Text] [Related]

  • 3. [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
    Zhao C, Li J, Hao F.
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):465-8. PubMed ID: 10436948
    [Abstract] [Full Text] [Related]

  • 4. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.
    Edlund C, Stark C, Nord CE.
    J Antimicrob Chemother; 1994 Jul; 34(1):127-38. PubMed ID: 7961199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
    Zuck P, Petitpretz P, Geslin P, Rio Y, Leblanc F.
    Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
    [Abstract] [Full Text] [Related]

  • 7. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
    Rossi R, Castellani P, Younes G, Della Bruna C.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
    [Abstract] [Full Text] [Related]

  • 8. [The influence of cefpodoxime proxetil on the intestinal bacterial flora].
    Iwata S, Yamada K, Kin Y, Yokota T, Kusumoto Y, Sato Y, Akita H, Nanri S, Oikawa T, Sunakawa K.
    Jpn J Antibiot; 1989 Jul; 42(7):1667-84. PubMed ID: 2681865
    [Abstract] [Full Text] [Related]

  • 9. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.
    Brismar B, Edlund C, Nord CE.
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):714-9. PubMed ID: 8243490
    [Abstract] [Full Text] [Related]

  • 10. Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
    Finegold SM, Ingram-Drake L, Gee R, Reinhardt J, Edelstein MA, MacDonald K, Wexler H.
    Antimicrob Agents Chemother; 1987 Mar; 31(3):443-6. PubMed ID: 3579262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
    Lorenz J.
    Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
    [Abstract] [Full Text] [Related]

  • 13. Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.
    Chachaty E, Depitre C, Mario N, Bourneix C, Saulnier P, Corthier G, Andremont A.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2009-13. PubMed ID: 1416894
    [Abstract] [Full Text] [Related]

  • 14. Effect of ceftaroline on normal human intestinal microflora.
    Panagiotidis G, Bäckström T, Asker-Hagelberg C, Jandourek A, Weintraub A, Nord CE.
    Antimicrob Agents Chemother; 2010 May; 54(5):1811-4. PubMed ID: 20231399
    [Abstract] [Full Text] [Related]

  • 15. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G, Ligozzi M, Bauernfeind A, Satta G, Fontana R.
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M, Vinciguerra A, Beghi GF, Paizis G, Giura R, Madonini V, Fiorentini F, Consigli GF, Tonna M, Casalini A.
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity and cross resistance studies with cefpodoxime.
    Grimm H.
    Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
    [Abstract] [Full Text] [Related]

  • 18. [Effects of azithromycin on fecal flora of healthy adult volunteers].
    Uchino U, Kanayama A, Hasegawa M, Kobayashi I, Muto H, Enogaki K, Matsunaga T, Ogawa M, Cyong JC, Kodama K.
    Jpn J Antibiot; 1995 Sep; 48(9):1119-30. PubMed ID: 7474332
    [Abstract] [Full Text] [Related]

  • 19. Impact of cefixime on the normal intestinal microflora.
    Nord CE, Movin G, Stålberg D.
    Scand J Infect Dis; 1988 Sep; 20(5):547-52. PubMed ID: 3222669
    [Abstract] [Full Text] [Related]

  • 20. [The effect of cefixime (CFIX) on intestinal bacterial flora].
    Iwata S, Yokota T, Kusumoto Y, Shiro H, Sato Y, Akita H, Nanri S, Oikawa T, Ishikawa K, Kumagai N.
    Kansenshogaku Zasshi; 1986 Jun; 60(6):549-73. PubMed ID: 3097196
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.